Supplier profile
Roche Products Ltd
Every public-sector award we hold for this supplier, across the UK and UK, from 1 Aug 2008 to 27 Aug 2026.
Awards won
308
all time
Attributed value
£104.0m + €56.6m
263 shared, unvalued
Buyers
61
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’) | 8 | £52.5m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 19 | £27.4m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS”) | 1 | £23.8m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’) | 7 | £250k |
| Business Energy and Industrial Strategy | 1 | £1 |
| Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency | 1 | £1 |
| NHS England | 86 | not attributable |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 19 | not attributable |
| The NHS Commissioning Board (operating under the name of NHS England) | 18 | not attributable |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 17 | €6.4m |
What they win
Awards
Showing 26–50 of 308 awards we hold
- NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 ↗NHS Englandshared awardawarded 1 Jul 2025
- NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 ↗NHS Englandshared awardawarded 1 Jul 2025
- NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 ↗NHS Englandshared awardawarded 1 Jul 2025
- Proprietary Drugs ↗eTenderwalesshared awardawarded 27 Jun 2025
- NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 ↗NHS Englandshared awardawarded 25 Jun 2025
- NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 ↗NHS Englandshared awardawarded 25 Jun 2025
- NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National ↗NHS Englandshared awardawarded 25 Jun 2025
- NHS National Generic Pharmaceuticals Wave 15b ↗NHS Englandshared awardawarded 16 Jun 2025
- NHS National Generic Pharmaceuticals Wave 15b ↗NHS Englandshared awardawarded 16 Jun 2025
- Medicinal Products and Pharma Funded Homecare [5749446] ↗Regional Business Services Organisation Procurement and Logistics Serviceshared awardawarded 12 Jun 2025
- Biologic and Biosimilar Medicines ↗eTenderwalesshared awardawarded 23 Apr 2025
- Transitional Drugs 3 ↗Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wshared awardawarded 15 Apr 2025
- Transitional Drugs 3 ↗Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trustsshared awardawarded 15 Apr 2025
- Rituximab Subcut ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)awarded 30 Jan 2025
- Trastuzumab (Herceptin®) 600mg/5ml solution for Injection ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)awarded 30 Jan 2025
- NP39724 Generic and Biosimilar Cancer Medicines ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)shared awardawarded 13 Jan 2025
- NP39724 Generic and Biosimilar Cancer Medicines ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)shared awardawarded 13 Jan 2025
- NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 ↗NHS Englandshared awardawarded 25 Jul 2024
- NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 ↗NHS Englandshared awardawarded 25 Jul 2024
- NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 ↗NHS Englandshared awardawarded 25 Jul 2024
- NHS Branded Medicines Tranche Framework for London and South of England ↗NHS Englandshared awardawarded 22 Jul 2024
- NHS Branded Medicines Tranche Framework for London and South of England ↗NHS Englandshared awardawarded 22 Jul 2024
- NHS Branded Medicines Tranche Framework for London and South of England ↗NHS Englandshared awardawarded 22 Jul 2024
- Generic, Branded Generic & Proprietary Medicinal Products - Group 14 ↗Procurement & Logistics Serviceshared awardawarded 2 Jul 2024
- Generic, Branded Generic & Proprietary Medicinal Products - Group 14 ↗Procurement & Logistics Serviceshared awardawarded 2 Jul 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.